EYL.20.09.0054
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) PatientNovember 7th 2025
Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?July 30th 2025
Growth Factor Supplementation: A New Paradigm in Ocular Surface Disease ManagementSeptember 19th 2024
Best Practices for Monitoring and Management of OT Teprotumumab-Associated Hearing ImpairmentJune 19th 2024